foxo4-dri senolytic mice baar 2017 Frontiers FOXO4-DRI: Kill Senescent Cells, Restore

A molecule that can activate telomerase or modulate circadian genes is only useful if it reaches its target intact

Insurance coverage exists for FDA-approved Tirzepatide under specific diabetes and weight management criteria, whereas investigational Survodutide has no coverage pathway outside research studies

Potential risks and contraindications Given the limited understanding of DSIPs mechanisms and effects in humans, certain risks and contraindications must be taken into consideration: Unknown long-term effects : The long-term safety of DSIP has not been well-established, and the potential risks associated with chronic use remain unclear

S.Gutirrez-de-TernH.et al (2016a)